{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:03:25Z","timestamp":1773867805506,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatitis B virus (HBV) causes both acute and chronic infection of the human liver and is associated with the development of liver cirrhosis and hepatocellular carcinoma. UBP43 (USP18) is known as an ISG15-deconjugating enzyme and an inhibitor of type I IFN signaling independent of its enzyme activity. In this study, we examined the role of these two previously identified functions of UBP43 in the innate immune response to HBV viral infection. As an in vivo HBV replication model system, a replication-competent DNA construct was injected hydrodynamically into the tail veins of mice. Although the lack of ISG15 conjugation in the absence of ISG15-activating enzyme UBE1L (UBA7) did not affect the level of HBV replication, the steady-state level of HBV DNA was substantially reduced in the UBP43-deficient mice in comparison to the wild-type controls. In addition, introduction of short hairpin RNA against UBP43 resulted in substantially lower levels of HBV DNA at day 4 postinjection and higher levels of ISG mRNAs. These results suggest that HBV infection is more rapidly cleared if UBP43 expression is reduced. Furthermore, these results illustrate the therapeutic potential of modulating UBP43 levels in treating viral infection, especially for viruses sensitive to IFN signaling.<\/jats:p>","DOI":"10.4049\/jimmunol.181.9.6467","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T23:03:28Z","timestamp":1397862208000},"page":"6467-6472","source":"Crossref","is-referenced-by-count":65,"title":["The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression"],"prefix":"10.1093","volume":"181","author":[{"given":"Jung-Hwan","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Molecular and Experimental Medicine, The Scripps Research Institute , La Jolla, CA 92037"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiann-Kae","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Molecular and Experimental Medicine, The Scripps Research Institute , La Jolla, CA 92037"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Er","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Molecular and Experimental Medicine, The Scripps Research Institute , La Jolla, CA 92037"},{"name":"Department of Pathology, Division of Biology, and Moores University of California San Diego Cancer Center, University of California San Diego , La Jolla, CA 92093"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"key":"2025032608470326700_R1","first-page":"221","article-title":"Hepatitis B virus replication","volume-title":"Trends Microbiol.","year":"1993"},{"key":"2025032608470326700_R2","first-page":"651","article-title":"The molecular biology of the hepatitis B viruses","volume-title":"Annu. Rev. Biochem.","year":"1987"},{"key":"2025032608470326700_R3","first-page":"1733","article-title":"Hepatitis B virus infection","volume-title":"N. Engl. J. Med.","year":"1997"},{"key":"2025032608470326700_R4","first-page":"374","article-title":"Initial and innate responses to viral infections-pattern setting in immunity or disease","volume-title":"Curr. Opin. Microbiol.","year":"1999"},{"key":"2025032608470326700_R5","first-page":"S182","article-title":"Therapy of hepatitis B: viral suppression or eradication?","volume-title":"Hepatology","year":"2006"},{"key":"2025032608470326700_R6","first-page":"2255","article-title":"Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines","volume-title":"J. Virol.","year":"2000"},{"key":"2025032608470326700_R7","first-page":"4165","article-title":"Intrahepatic induction of \u03b1\/\u03b2 interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice","volume-title":"J. Virol.","year":"2000"},{"key":"2025032608470326700_R8","first-page":"1583","article-title":"Signaling pathways activated by interferons","volume-title":"Exp. Hematol.","year":"1999"},{"key":"2025032608470326700_R9","first-page":"661","article-title":"Interferons \u03b1 and \u03b2 as immune regulators: a new look","volume-title":"Immunity","year":"2001"},{"key":"2025032608470326700_R10","first-page":"255","article-title":"Viruses and interferons","volume-title":"Annu. Rev. Microbiol.","year":"2001"},{"key":"2025032608470326700_R11","first-page":"237","article-title":"Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis","volume-title":"Apoptosis","year":"2003"},{"key":"2025032608470326700_R12","first-page":"8","article-title":"Interferons, interferon-like cytokines, and their receptors","volume-title":"Immunol. Rev.","year":"2004"},{"key":"2025032608470326700_R13","first-page":"324","article-title":"Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin","volume-title":"J. Biol. Chem.","year":"1996"},{"key":"2025032608470326700_R14","first-page":"237","article-title":"ISG15: the immunological kin of ubiquitin","volume-title":"Semin. Cell Dev. Biol.","year":"2004"},{"key":"2025032608470326700_R15","first-page":"362","article-title":"Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein","volume-title":"EMBO J.","year":"2001"},{"key":"2025032608470326700_R16","first-page":"9592","article-title":"Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation","volume-title":"Mol. Cell. Biol.","year":"2004"},{"key":"2025032608470326700_R17","first-page":"7578","article-title":"The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-\u03b1\/\u03b2-induced ubiquitin-like protein","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2004"},{"key":"2025032608470326700_R18","first-page":"2701","article-title":"ISG15: a ubiquitin-like enigma","volume-title":"Front. Biosci.","year":"2005"},{"key":"2025032608470326700_R19","first-page":"3989","article-title":"The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase","volume-title":"J. Biol. Chem.","year":"2006"},{"key":"2025032608470326700_R20","first-page":"10735","article-title":"HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2006"},{"key":"2025032608470326700_R21","first-page":"4334","article-title":"Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells","volume-title":"J. Biol. Chem.","year":"2006"},{"key":"2025032608470326700_R22","first-page":"255","article-title":"ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP","volume-title":"Genes Dev.","year":"2007"},{"key":"2025032608470326700_R23","first-page":"9976","article-title":"UBP43 (USP18) specifically removes ISG15 from conjugated proteins","volume-title":"J. Biol. Chem.","year":"2002"},{"key":"2025032608470326700_R24","first-page":"2207","article-title":"Dysregulation of protein modification by ISG15 results in brain cell injury","volume-title":"Genes Dev.","year":"2002"},{"key":"2025032608470326700_R25","first-page":"455","article-title":"Protein ISGylation modulates the JAK-STAT signaling pathway","volume-title":"Genes Dev.","year":"2003"},{"key":"2025032608470326700_R26","first-page":"193","article-title":"Microarray analysis reveals that Type I interferon strongly increases the expression of immunoresponse related genes in Ubp43 (Usp18) deficient macrophages","volume-title":"Biochem. Biophys. Res. Commun.","year":"2007"},{"key":"2025032608470326700_R27","first-page":"1374","article-title":"Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection","volume-title":"Nat. Med.","year":"2004"},{"key":"2025032608470326700_R28","first-page":"2358","article-title":"UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity","volume-title":"EMBO J.","year":"2006"},{"key":"2025032608470326700_R29","first-page":"207","article-title":"Expression and replication of hepatitis B virus genome in transgenic mice","volume-title":"Proc. Natl. Acad. Sci. USA","year":"1989"},{"key":"2025032608470326700_R30","first-page":"6158","article-title":"High-level hepatitis B virus replication in transgenic mice","volume-title":"J. Virol.","year":"1995"},{"key":"2025032608470326700_R31","first-page":"1258","article-title":"Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA","volume-title":"Gene Ther.","year":"1999"},{"key":"2025032608470326700_R32","first-page":"1735","article-title":"High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA","volume-title":"Hum. Gene Ther.","year":"1999"},{"key":"2025032608470326700_R33","first-page":"13825","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2002"},{"key":"2025032608470326700_R34","first-page":"472","article-title":"Ube1L and protein ISGylation are not essential for \u03b1\/\u03b2 interferon signaling","volume-title":"Mol. Cell. Biol.","year":"2006"},{"key":"2025032608470326700_R35","first-page":"13974","article-title":"Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo","volume-title":"J. Virol.","year":"2005"},{"key":"2025032608470326700_R36","first-page":"1371","article-title":"IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2007"},{"key":"2025032608470326700_R37","first-page":"1440","article-title":"Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2006"},{"key":"2025032608470326700_R38","first-page":"5515","article-title":"A DNA vector-based RNAi technology to suppress gene expression in mammalian cells","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2002"},{"key":"2025032608470326700_R39","first-page":"16608","article-title":"High-throughput immunoblotting: ubiquitiin-like protein ISG15 modifies key regulators of signal transduction","volume-title":"J. Biol. Chem.","year":"2003"},{"key":"2025032608470326700_R40","first-page":"919","article-title":"Role of interferon-stimulated gene ISG-15 in the interferon-\u03c9-mediated inhibition of human immunodeficiency virus replication","volume-title":"J. Interferon Cytokine Res.","year":"1996"},{"key":"2025032608470326700_R41","first-page":"6338","article-title":"ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus","volume-title":"Mol. Cell. Biol.","year":"2005"},{"key":"2025032608470326700_R42","first-page":"847","article-title":"Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling","volume-title":"J. Immunol.","year":"2005"},{"key":"2025032608470326700_R43","first-page":"305","article-title":"Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling","volume-title":"Blood","year":"2007"},{"key":"2025032608470326700_R44","first-page":"1437","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume-title":"Gastroenterology","year":"2005"},{"key":"2025032608470326700_R45","first-page":"1584","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume-title":"Gastroenterology","year":"2006"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/181\/9\/6467\/62583115\/7997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/181\/9\/6467\/62583115\/7997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:46:24Z","timestamp":1743255984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/181\/9\/6467\/8007964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,1]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.181.9.6467","relation":{},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,11]]},"published":{"date-parts":[[2008,11,1]]}}}